GP-73 is a type 2 Golgi transmembrane glycoprotein that has been reported to yield a higher sensitivity of 77.4-86.3% but a lower specificity than AFP assay in the early diagnosis of primary liver cancer [25]. Here, AFP is linked to liver cancer.